Increased CD36 Expression Signals Monocyte Activation Among Patients With Type 2 Diabetes
Article Figures & Tables
Tables
- Table 1
Unadjusted and adjusted mean CD36 mRNA/protein and Pearson product moment correlations (r)
CD36 mRNA (log r.u.) CD36 protein (log r.u.) Type 2 diabetes Nondiabetic control subjects Type 2 diabetes Nondiabetic control subjects n 33 27 33 27 Unadjusted mean 0.23 ± 0.02† 0.16 ± 0.02 0.28 ± 0.02§ 0.18 ± 0.02 Model 1 0.21 ± 0.02 0.17 ± 0.02 0.27 ± 0.01* 0.21 ± 0.02 Model 2 0.20 ± 0.02 0.18 ± 0.02 0.26 ± 0.01† 0.20 ± 0.01 CD36 mRNA (log r.u.) NA NA r = 0.64‡ r = 0.63‡ PPAR-γ mRNA (log r.u.) r = 0.73‡ r = 0.72‡ r = 0.33# r = 0.46* hsCRP (log mg/dl) r = 0.55† r = 0.21 r = 0.45† r = 0.43* hsIL-6 (log pg/ml) r = 0.40* r = 0.49† r = 0.64‡ r = 0.49† TNF-α (log pg/ml) r = −0.20 r = 0.09 r = −0.28 r = −0.02 Adiponectin (log μg/ml) r = −0.61‡ r = −0.67‡ r = −0.60‡ r = −0.56† BMI (kg/m2) r = 0.20 r = 0.03 r = 0.09 r = 0.17 HOMA-IR (log r.u.) r = 0.18 r = 0.03 r = 0.12 r = −0.07 QUICKI (log r.u.) r = −0.20 r = 0.05 r = −0.16 r = 0.19 Data are least squares means ± SEM unless otherwise indicated. The P value is from a t test of equality of the means. Model 1 adjusts for hypertension (HTN), hsIL-6, PPAR, adiponectin, and QUICKI. Model 2 adjusts for hsIL-6, adiponectin, and QUICKI.
↵*P < 0.05,
↵†P < 0.01,
↵‡P < 0.001,
↵§P < 0.0001,
↵#P = 0.08. HOMA-IR, homeostasis model assessment–insulin resistance; QUICKI, quantitative insulin sensitivity check index; r.u., relative units.